دورية أكاديمية
أعرض في EDS

Revisiting the Immunometabolic Basis for the Metabolic Syndrome from an Immunonutritional View.

التفاصيل البيبلوغرافية
العنوان: Revisiting the Immunometabolic Basis for the Metabolic Syndrome from an Immunonutritional View.
المؤلفون: Apaza CJ; Madrid Institute for Advanced Studies in Food (IMDEA Food), Carretera Cantoblanco 8, 28049 Madrid, Spain.; Bioactivity and Nutritional Immunology Group (BIOINUT), Valencian International University (VIU), Pintor Sorolla 21, 46002 Valencia, Spain., Cerezo JF; Madrid Institute for Advanced Studies in Food (IMDEA Food), Carretera Cantoblanco 8, 28049 Madrid, Spain., García-Tejedor A; Bioactivity and Nutritional Immunology Group (BIOINUT), Valencian International University (VIU), Pintor Sorolla 21, 46002 Valencia, Spain., Giménez-Bastida JA; Research Group on Quality, Safety and Bioactivity of Plant Foods, Campus de Espinardo, CEBAS-CSIC, P.O. Box 164, 30100 Murcia, Spain., Laparra-Llopis JM; Madrid Institute for Advanced Studies in Food (IMDEA Food), Carretera Cantoblanco 8, 28049 Madrid, Spain.; Bioactivity and Nutritional Immunology Group (BIOINUT), Valencian International University (VIU), Pintor Sorolla 21, 46002 Valencia, Spain.
المصدر: Biomedicines [Biomedicines] 2024 Aug 12; Vol. 12 (8). Date of Electronic Publication: 2024 Aug 12.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI AG, [2013]-
مستخلص: Metabolic syndrome (MetS) implies different conditions where insulin resistance constitutes a major hallmark of the disease. The disease incurs a high risk for the development of cardiovascular complications, and takes its toll in regard to the gut-liver axis (pancreas, primary liver and colorectal)-associated immunity. The modulation of immunometabolic responses by immunonutritional factors (IFs) has emerged as a key determinant of the gut-liver axis' metabolic and immune health. IFs from plant seeds have shown in vitro and pre-clinical effectiveness primarily in dealing with various immunometabolic and inflammatory diseases. Only recently have immunonutritional studies established the engagement of innate intestinal immunity to effectively control immune alterations in inflamed livers preceding the major features of the MetS. However, integrative analyses and the demonstration of causality between IFs and specific gut-liver axis-associated immunometabolic imbalances for the MetS remain ill-defined in the field. Herein, a better understanding of the IFs with a significant role in the MetS, as well as within the dynamic interplay in the functional differentiation of innate immune key effectors (i.e., monocytes/macrophages), worsening or improving the disease, could be of crucial relevance. The development of an adequate intermediary phenotype of these cells can significantly contribute to maintaining the function of T regs and innate lymphoid cells for the prevention and treatment of MetS and associated comorbidities.
References: Eur J Clin Invest. 2013 Feb;43(2):215-24. (PMID: 23289518)
Circulation. 2009 Oct 20;120(16):1640-5. (PMID: 19805654)
Diabetes. 2013 Oct;62(10):3394-403. (PMID: 23835343)
Obesity (Silver Spring). 2015 Jul;23(7):1394-400. (PMID: 26052894)
N Engl J Med. 2002 Jul 18;347(3):185-92. (PMID: 12124407)
Metabolism. 2017 Sep;74:1-9. (PMID: 28764843)
Gut. 2018 Jan;67(1):157-165. (PMID: 28011892)
Curr Hypertens Rep. 2018 Feb 26;20(2):12. (PMID: 29480368)
J Clin Invest. 2017 Jan 3;127(1):1-4. (PMID: 28045402)
Nat Metab. 2023 May;5(5):735-759. (PMID: 37142787)
Science. 2010 Apr 9;328(5975):228-31. (PMID: 20203013)
Front Immunol. 2021 Feb 19;11:587229. (PMID: 33679687)
Nat Rev Endocrinol. 2020 Dec;16(12):731-739. (PMID: 33106657)
Endocrinology. 2021 Jun 1;162(6):. (PMID: 33765141)
World J Diabetes. 2010 Jul 15;1(3):89-98. (PMID: 21537432)
Front Immunol. 2019 Aug 06;10:1788. (PMID: 31447835)
Endocrinology. 2019 May 1;160(5):1021-1030. (PMID: 30807635)
World J Diabetes. 2017 Jun 15;8(6):304-310. (PMID: 28694931)
Cell Rep. 2023 May 30;42(5):112424. (PMID: 37086405)
Lipids Health Dis. 2023 Oct 4;22(1):165. (PMID: 37794473)
Nutrients. 2021 Nov 29;13(12):. (PMID: 34959869)
Adv Nutr. 2016 Jan 15;7(1):66-75. (PMID: 26773015)
Front Immunol. 2022 Oct 04;13:982827. (PMID: 36268010)
Nat Rev Immunol. 2019 May;19(5):291-304. (PMID: 30679807)
Eur J Nutr. 2010 Aug;49(5):311-9. (PMID: 20035337)
Endocr Rev. 2008 Dec;29(7):777-822. (PMID: 18971485)
Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):979-84. (PMID: 17210919)
Oncotarget. 2019 Jan 22;10(7):760-772. (PMID: 30774778)
Front Immunol. 2021 Sep 17;12:752359. (PMID: 34603340)
Cell Mol Immunol. 2022 Mar;19(3):327-336. (PMID: 35017717)
Hepatology. 2016 Jul;64(1):73-84. (PMID: 26707365)
Cell Metab. 2021 Aug 3;33(8):1610-1623.e5. (PMID: 34256015)
Dig Dis Sci. 2016 May;61(5):1294-303. (PMID: 26841783)
Food Funct. 2024 Apr 2;15(7):3600-3614. (PMID: 38469889)
Aging (Albany NY). 2020 Nov 20;12(24):25819-25827. (PMID: 33232281)
J Inflamm Res. 2019 Aug 21;12:205-217. (PMID: 31686890)
Int J Mol Sci. 2022 Oct 21;23(20):. (PMID: 36293536)
Immunity. 2011 Feb 25;34(2):213-23. (PMID: 21349431)
J Immunol. 2017 Feb 1;198(3):1006-1014. (PMID: 28115590)
Metabolism. 2022 Nov;136:155272. (PMID: 35914622)
Life Sci. 2021 Dec 15;287:120129. (PMID: 34774619)
Nature. 2018 Feb 8;554(7691):255-259. (PMID: 29364878)
Immunobiology. 2020 Jan;225(1):151874. (PMID: 31810825)
Front Immunol. 2020 Jul 22;11:1582. (PMID: 32793223)
Hepatology. 2012 Mar;55(3):769-80. (PMID: 21987488)
Lifestyle Genom. 2020;13(6):164-171. (PMID: 33075772)
J Virol. 2013 Mar;87(6):3261-70. (PMID: 23302870)
PLoS One. 2012;7(10):e48250. (PMID: 23144745)
Cell Rep. 2017 Mar 7;18(10):2415-2426. (PMID: 28273456)
Mol Nutr Food Res. 2014 Jul;58(7):1519-27. (PMID: 24753491)
Am J Clin Nutr. 2021 Dec 1;114(6):1873-1885. (PMID: 34515299)
Cell Rep. 2019 Jul 2;28(1):202-217.e7. (PMID: 31269440)
Mucosal Immunol. 2018 May;11(3):727-740. (PMID: 29363671)
Ann Nutr Metab. 2011;58 Suppl 2:44-52. (PMID: 21846980)
Obes Res. 2005 Dec;13(12):2122-31. (PMID: 16421346)
Vitam Horm. 2009;80:613-33. (PMID: 19251052)
Am J Epidemiol. 2013 Jul 1;178(1):38-45. (PMID: 23703888)
Endocrinol Diabetes Nutr. 2017 Feb;64(2):82-91. (PMID: 28440782)
Obes Sci Pract. 2017 Dec 14;4(1):85-96. (PMID: 29479468)
PLoS One. 2024 Mar 15;19(3):e0299836. (PMID: 38489287)
J Leukoc Biol. 1999 Oct;66(4):562-6. (PMID: 10534109)
Biochem Genet. 2019 Oct;57(5):695-708. (PMID: 30989422)
Am Heart J. 2004 Dec;148(6):1034-40. (PMID: 15632890)
Nat Immunol. 2012 Jul 19;13(8):707-12. (PMID: 22814340)
Am J Transl Res. 2016 Dec 15;8(12):5696-5705. (PMID: 28078040)
J Clin Invest. 2017 Jan 3;127(1):65-73. (PMID: 28045405)
Nat Med. 2011 Feb;17(2):179-88. (PMID: 21217695)
Biomed Environ Sci. 2016 Jul;29(7):505-15. (PMID: 27554120)
Cardiovasc Diabetol. 2010 Mar 23;9:11. (PMID: 20331890)
Obesity (Silver Spring). 2020 Feb;28(2):225-234. (PMID: 31903735)
Sci Rep. 2021 Feb 15;11(1):3840. (PMID: 33589701)
Mol Cell Endocrinol. 2015 Dec 15;418 Pt 1:55-65. (PMID: 25724480)
Int J Mol Sci. 2023 Dec 15;24(24):. (PMID: 38139364)
Nat Rev Endocrinol. 2016 Jan;12(1):15-28. (PMID: 26553134)
Biomed Res Int. 2015;2015:927589. (PMID: 25815341)
Eur J Nutr. 2012 Oct;51(7):841-50. (PMID: 22038464)
Diabetes Res Clin Pract. 2022 Jan;183:109119. (PMID: 34879977)
Science. 2021 Jul 2;373(6550):. (PMID: 34210853)
Nat Metab. 2023 Jun;5(6):981-995. (PMID: 37308721)
PLoS One. 2013 Apr 04;8(4):e58412. (PMID: 23593121)
Nature. 2017 Feb 8;542(7640):177-185. (PMID: 28179656)
Cell Rep. 2019 Jul 9;28(2):498-511.e5. (PMID: 31291584)
Sci Rep. 2016 Aug 31;6:31945. (PMID: 27578536)
Int J Mol Sci. 2016 Jun 13;17(6):. (PMID: 27304953)
Eur J Pharmacol. 2019 Nov 5;862:172657. (PMID: 31499040)
Curr Opin Lipidol. 2010 Feb;21(1):76-83. (PMID: 19915460)
Benef Microbes. 2014 Mar;5(1):33-43. (PMID: 24533976)
Foods. 2023 Sep 04;12(17):. (PMID: 37685253)
Metabolism. 2010 May;59(5):711-7. (PMID: 19922963)
Nutrition. 2019 Apr;60:1-5. (PMID: 30508762)
Semin Immunol. 2019 Feb;41:101271. (PMID: 30902413)
Nature. 2019 Apr;568(7752):405-409. (PMID: 30944470)
J Immunol. 2020 May 1;204(9):2503-2513. (PMID: 32205424)
Diabetes Technol Ther. 2006 Feb;8(1):55-66. (PMID: 16472051)
Diabetes Metab. 2012 Dec;38(6):538-43. (PMID: 23182460)
Proc Natl Acad Sci U S A. 2018 Jul 3;115(27):E6254-E6263. (PMID: 29891687)
Front Neurosci. 2019 May 08;13:462. (PMID: 31133793)
J Clin Invest. 2003 Dec;112(12):1796-808. (PMID: 14679176)
Nutr Metab Cardiovasc Dis. 2009 Feb;19(2):e5-6. (PMID: 19176284)
J Genet. 2017 Mar;96(1):53-64. (PMID: 28360390)
Cell Immunol. 2009;258(2):138-46. (PMID: 19423085)
Endocrinology. 1992 Oct;131(4):1695-702. (PMID: 1396316)
Am J Clin Nutr. 2013 Aug;98(2):586S-93S. (PMID: 23824726)
معلومات مُعتمدة: PID2019-107650RB-C22 Ministry of Science, Innovation and Universities (Spain)
فهرسة مساهمة: Keywords: immunonutrition; insulin resistance; macrophage; metabolic syndrome; obesity; type 2 diabetes
تواريخ الأحداث: Date Created: 20240829 Latest Revision: 20240901
رمز التحديث: 20240901
مُعرف محوري في PubMed: PMC11352112
DOI: 10.3390/biomedicines12081825
PMID: 39200288
قاعدة البيانات: MEDLINE
الوصف
تدمد:2227-9059
DOI:10.3390/biomedicines12081825